Why the study?
Bright morning light modulates circadian rhythms and improves sleep-wake disturbances, but its impact on the autonomic nervous system at night remains unclear.
Does bright morning light exposure enhance parasympathetic nervous system activity at night in older people with dementia?
Does bright morning light exposure enhance parasympathetic nervous system activity at night in older people with dementia?
Bright morning light exposure enhances parasympathetic activity and reduces sympathetic activity at night in older patients with dementia, potentially offering a clinical tool to alleviate cognitive deterioration.
May enhance nocturnal PSNS activity in dementia; leaves open effects on outcomes and need for RCTs.
Bright morning light (BML) entrains the body clock, modulates circadian rhythm, and improves sleep-wake disturbances. However, its impact on the autonomic nervous system (ANS) at night remains unclear. Hence, we investigated the effects of BML exposure on activities of the parasympathetic nervous system (PSNS) and sympathetic nervous system (SNS) at night. This non-randomized controlled pilot study included participants ≥60 years, diagnosed with a type of dementia or cognitive disorder. We excluded participants with pacemakers. The treatment group received 2500 lx BML, whereas the control group received approximately 200 lx of general lighting. We measured the heart rate variability to quantify ANS activity. The treatment group displayed significantly increased high-frequency (HF) power (Roy's largest root=2.44; P<.01) and insignificantly decreased normalized low-frequency (LF%) power. The corresponding low-frequency/high-frequency ratio (LF/HF), insignificant decrease, and cognitive function were correlated with PSNS activity (Roy's largest root=3.92; P<.01), which is effective for moderate dementia. BML exposure reduced SNS activity and enhanced PSNS activity at night, which consequently affected cognitive function. Furthermore, the light washout intervention markedly increased SNS activity at night. BML therapy may be a useful clinical tool for alleviating the deterioration of cognitive function.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: